Tharimmune(US:THAR)2026-01-30 16:02Summary of Tharimmune, Inc. Special Meeting Company Overview - Company: Tharimmune, Inc. (NasdaqCM:THAR) - Meeting Date: January 30, 2026 - Key Participants: Mark Wendland (CEO), Jacob Asbury (CFO), Francis H. Bird (Inspector of Election) Key Proposals and Votes 1. Election of Directors - Two directors nominated: Jill E. Summers and William Wiley - Each nominee's term expires at the next annual meeting - Requires a plurality of votes to be elected - Outcome: Approved [12] 2. Issuance of Shares for Strategic Advisor Warrants - Proposal to approve issuance of shares upon exercise of Strategic Advisor Warrants - Requires majority vote for approval - Outcome: Approved [12] 3. Issuance of Shares for Cryptocurrency Pre-Funded Warrants - Proposal related to shares issued in connection with a private placement on November 3, 2025 - Requires majority vote for approval - Outcome: Approved [13] 4. Issuance of Restricted Stock Units to Clear Street, LLC - Proposal for issuance of restricted stock units and common stock upon settlement - Requires majority vote for approval - Outcome: Approved [13] 5. Amendment to the 2023 Omnibus Equity Incentive Plan - Proposal to increase the number of shares available for issuance by 7 million shares - Requires majority vote for approval - Outcome: Approved [13] 6. Adjournment of the Meeting - Proposal to approve adjournments if necessary for further solicitation of votes - Requires majority vote for approval - Outcome: Approved [13] Additional Information - Voting Process: Shareholders were informed that abstentions would count as votes against the proposals [5][9] - Quorum: A quorum of shareholders was present, allowing the meeting to proceed lawfully [3] - No Questions Submitted: There were no questions from shareholders during the meeting [11] Conclusion - The special meeting concluded with all proposals being approved, indicating strong shareholder support for the company's strategic initiatives and governance [14]